Search clinical trials for: Selective Estrogen Receptor Modulators

Total 3761 results

Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Symptoms Associated With Menopause

Vasomotor Symptoms Associated With Menopause

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Bazedoxifene/CE in Postmenopausal Women

Postmenopause
University of North Carolina, Chapel Hill
Foundation of Hope, North Carolina

Completed

Effects of a Tissue Selective Estrogen Complex (TSEC) on Depression and the Neural Reward System in the Perimenopause" (Duavee)

Depression | Perimenopausal Disorder

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Vasomotor Symptoms Associated With Menopause

Vaginal Atrophy

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Potential Drug Interaction Of Bazedoxifene & Premarin In Healthy Postmenopausal Women

Postmenopause

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Bioequivalence Study Of Bazedoxifene/Conjugated Estrogen Tablets In Postmenopausal Women

Menopause
University of Kansas Medical Center
Pfizer

Completed

Pilot Study of the Effect of Duavee® on Benign Breast Tissue Proliferation

Breast Cancer

United States
University of Kansas Medical Center
National Cancer Institute (NCI)

Recruiting

Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens

Breast Cancer | Risk Reduction

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Three Bazedoxifene/Conjugated Estrogens Combination Tablet Formulations Versus BZA Oral Solution

Postmenopause
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Of Pharmacokinetic (PK) Profile of Bazedoxifene (BZA) in 2 BZA/Conjugated Estrogen Forms

Postmenopause

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Formulations of Bazedoxifene/Conjugated Estrogens

Healthy
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations in Fed and Fasting in Healthy, Postmenopausal Women

Healthy

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Safety and Efficacy of Bazedoxifene/Conjugated Estrogens Combinations in Postmenopausal Women

Endometrial Hyperplasia | Osteoporosis
Pfizer

Completed

Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Postmenopausal Women

Endometrial Hyperplasia | Osteoporosis

United States
Pfizer

Terminated

A Pilot Bioavailability Study of 3 Test Tablet Formulations of Bazedoxifene Compared With A Reference Tablet Formulation of Bazedoxifene/Conjugated Estrogens in Healthy Postmenopausal Women

Healthy

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Healthy Postmenopausal Women

Menopause
Carol Fabian, MD

Active, not recruiting

Pilot Study of Bazedoxifene Plus Conjugated Estrogen on Imaging and Blood Biomarkers

Increased Risk for Development of Breast Cancer

United States
University of Oxford
National Institute for Health Research, United Kingdom; Oxford Clinical Trials...

Completed

Can we Use Estrogen-containing Therapy to Improve Pain in Women After Menopause With Hand Osteoarthritis? (HOPE-e)

Hand Osteoarthritis

United Kingdom
University of Southern California
National Institute on Aging (NIA)

Recruiting

Advancing Postmenopausal Preventive Therapy (APPT)

Atherosclerosis | Cognitive Decline

United States
National Institute on Aging (NIA)

Completed

AFTER: Altering Fat Through Estrogen and Raloxifene

Postmenopause

United States
Laval University
V Joseph; C Minville; C Rheaume

Recruiting

Impact of Estrogen + Estradiol Receptor Alpha Modulator Therapy on Oxidative Stress in Post-menopausal Women With and Without Sleep Apnea (Alpha MenoX)

Sleep Apnea | Oxidative Stress | Post Menopausal

Canada
Carol Fabian, MD
Breast Cancer Research Foundation

Terminated

Pilot Study of Effects of Duavee® on Imaging and Blood Biomarkers In Women With Menopausal Symptoms

Focus of Study is Healthy Women at Risk for Breast Cancer

United States
Veru Inc.

Withdrawn

Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast Cancer

Metastatic Breast Cancer

United States
The Alfred
Stanley Medical Research Institute

Completed

The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder

Australia
Bayer

Completed

3-year Study of Menostar Versus Evista to Prevent Osteoporosis in Post-menopausal Women

Osteopenia
VA Office of Research and Development

Not yet recruiting

Effects of Novel Estrogens on Glucose and Lipids in Postmenopausal Prediabetic Women Veterans (CE/BZA)

Obesity | Menopause | Prediabetes

United States
Tulane University Health Sciences Center

Completed

Bazedoxifene/Conjugated Estrogens (BZA/CE) Improvement of Metabolism (BIM) (BIM)

Obesity | Glucose Homeostasis | Postmenopausal Symptoms

United States
University of Southern California
AstraZeneca

Terminated

A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS)

Breast Carcinoma

United States
Pfizer

Completed

Viviant 20mg Special Investigation (Regulatory Post Marketing Commitment Plan) (VIOLINE)

Osteoporosis
Eli Lilly and Company

Completed

Raloxifene Use for The Heart

Cardiovascular Diseases | Breast Neoplasms

United States
Northwestern University
National Cancer Institute (NCI)

Completed

Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer

Endometrial Cancer

United States
Fundació Sant Joan de Déu

Completed

Double Blind, Placebo-controlled Study of Raloxifene for Negative Symptoms of Schizophrenia in Postmenopausal Women

Schizophrenia

Spain
Icahn School of Medicine at Mount Sinai
AstraZeneca

Terminated

Examination of Breast Cancer Cells of Pre-menopausal and Post-menopausal Women Before and After Exposure to Tamoxifen or Fulvestrant.

Breast Cancer

United States
US Department of Veterans Affairs

Completed

Estrogen Alternatives Study

Healthy

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Bazedoxifene Dose-Response in Japanese Patients With Postmenopausal Osteoporosis.

Postmenopausal Osteoporosis
Eunice Kennedy Shriver National Institute of Child...

Completed

The Safety and Effectiveness of Surgery With or Without Raloxifene for the Treatment of Pelvic Pain Caused by Endometriosis

Endometriosis | Pelvic Pain

United States
Iris Sommer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Ziekenhuis... and other collaborators

Completed

Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder (RAPSODI)

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | Psychosis NOS

Netherlands
Erasmus Medical Center

Recruiting

Tamoxifen Prediction Study in Patients With ER+ Breast Cancer (PREDICTAM)

ER+ Breast Cancer

Netherlands
Nalagenetics Pte Ltd
Indonesia University; SJH Initiatives; MRCCC Siloam Hospitals Semanggi

Active, not recruiting

CYP2D6 Genotypes and Breast Cancer Clinical Outcomes in the Indonesian Population

Breast Cancer

Indonesia
Toshihiko Kono

Unknown

The Effects of Seasonal Changes in Osteoporosis Treatment

Selective Estrogen Receptor Modulator (SERM)

Japan
National Cancer Center, Korea

Terminated

Evaluation of the Association Between CYP2D6 Genetic Polymorphisms and the Treatment Effect of Tamoxifen

Breast Cancer | Metastatic Disease

Korea, Republic of
AstraZeneca

Completed

A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer

Breast Cancer | Metastasis

United States, Australia, Brazil, France, Italy, Mexico, Russian Federation, South Africa, Spain, Turkey, United Kingdom, Poland, Japan, Argentina, Austria, Canada, Hungary, Israel, Netherlands, New Zealand, Portugal, Taiwan, Germany, Finlan... and more
National Cancer Centre, Singapore
National Medical Research Council (NMRC), Singapore

Active, not recruiting

Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376

Breast Cancer

Singapore
Dompé Farmaceutici S.p.A

Completed

Multicenter Double Blind, Parallel-group Phase 2/3 Trial, to Study Raloxifene in Adult COVID-19 Patients.

SARS CoV 2 Infection

France, Spain, Italy
Hadassah Medical Organization

Completed

Treatment Effect of Tamoxifen on Patients With DMD

Duchenne Muscular Dystrophy
Roswell Park Cancer Institute
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

Analyzing a New Mechanism in Response to Tamoxifen Therapy in Breast Cancer Patients

Breast Cancer

United States
National Institute of Mental Health (NIMH)

Completed

Examination of Tamoxifen in Acute Mania in Patients With Bipolar I Disorder

Bipolar Disorder

United States
Vanderbilt University
Washington University School of Medicine; Instituto National de Cancerologia...

Completed

Neoadjuvant Tamoxifen in Locally Advanced Breast Cancer in a Low/Middle Income Country

Breast Cancer | Breast Neoplasms
Northwestern University
National Cancer Institute (NCI)

Completed

Effect of 4-Hydroxytamoxifen Gel on Breast Density, Salivary Sex Steroids, and Quality of Life in Premenopausal Women

Breast Cancer

United States
King Faisal Specialist Hospital & Research Center

Unknown

Post Operative Adjuvant Chemotherapy Followed by Adjuvant Tamoxifen vs Nil for Patients With Operable Breast Cancer

Breast Cancer

Search clinical trials for: Selective Estrogen Receptor Modulators

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Benin

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations